Evidence map›Paper›PMID 26432096›Full record

ArticlePsychopharmacology2016

Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala.

Joshua D Larkin, Nicole L Jenni, Stan B Floresco

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Sex differences in sensitivity to dopamine receptor manipulations of risk-based decision making in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Neurosteroids and the mesocorticolimbic system.Neuroscience and biobehavioral reviews · 2023
    Review
  10. Dopamine D2 receptors in nucleus accumbens cholinergic interneurons increase impulsive choice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Distinct Medial Orbitofrontal-Striatal Circuits Support Dissociable Component Processes of Risk/Reward Decision-Making.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Activation of Nigrostriatal Dopamine Neurons during Fear Extinction Prevents the Renewal of Fear.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joshua D LarkinDepartment of Psychology and Brain Research Centre, University of British Columbia, Vancouver, British Columbia, V6T 1Z4, Canada.
Nicole L JenniDepartment of Psychology and Brain Research Centre, University of British Columbia, Vancouver, British Columbia, V6T 1Z4, Canada.
Stan B FlorescoDepartment of Psychology and Brain Research Centre, University of British Columbia, Vancouver, British Columbia, V6T 1Z4, Canada. floresco@psych.ubc.ca.

Funding

Canadian Institutes of Health Research MOP 89861
6 · The paper itself

Abstract

rationaleDopamine (DA) transmission within cortico-limbic-striatal circuitry is integral in modulating decisions involving reward uncertainty. The basolateral amygdala (BLA) also plays a role in these processes, yet how DA transmission within this nucleus regulates cost/benefit decision making is unknown.

objectivesWe investigated the contribution of DA transmission within the BLA to risk/reward decision making assessed with a probabilistic discounting task.

methodsRats were well-trained to choose between a small/certain reward and a large/risky reward, with the probability of obtaining the larger reward decreasing (100-12.5 %) or increasing (12.5-100 %) over a session. We examined the effects of antagonizing BLA D1 (SCH 23390, 0.1-1 μg) or D2 (eticlopride, 0.1-1 μg) receptors, as well as intra-BLA infusions of agonists for D1 (SKF 81297, 0.1-1 μg) and D2 (quinpirole, 1-10 μg) receptors. We also assessed how DA receptor stimulation may induce differential effects related to baseline levels of risky choice.

resultsBLA D1 receptor antagonism reduced risky choice by decreasing reward sensitivity, whereas D2 antagonism did not affect overall choice patterns. Stimulation of BLA D1 receptors optimized decision making in a baseline-dependent manner: in risk-averse rats, infusions of a lower dose of SKF81297 increased risky choice when reward probabilities were high (50 %), whereas in risk-prone rats, this drug reduced risky choice when probabilities were low (12.5 %). Quinpirole reduced risky choice in risk-prone rats, enhancing lose-shift behavior.

conclusionsThese data highlight previously uncharacterized roles for BLA DA D1 and D2 receptors in biasing choice during risk/reward decision making through mediation of reward/negative feedback sensitivity.

Indexed as

RewardRisk-TakingAnimalsBasolateral Nuclear ComplexChoice BehaviorDecision MakingDopamineDopamine AgonistsDopamine AntagonistsMaleRatsRats, Long-EvansReceptors, Dopamine D1Receptors, Dopamine D2Synaptic TransmissionDopamineDopamine AgonistsDopamine AntagonistsReceptors, Dopamine D1Receptors, Dopamine D2Basolateral amygdalaDecision makingDopamineProbabilistic discountingRatRisk

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.